Chorionic gonadotrophin (human) Other names: hCG

Therapeutic indications

Chorionic gonadotrophin (human) is indicated for:

Delayed puberty

Population group: men, only adolescents (12 years - 18 years old)

Delayed puberty associated with insufficient gonadotrophic pituitary function.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypogonadotrophic hypogonadism

Population group: men, only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Hypogonadotropic hypogonadism

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Sterility

Population group: men, only adults (18 - 65 years old)

Sterility in selected cases of deficient spermatogenesis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Sterility

Population group: women, only adults (18 - 65 years old)

Sterility due to the absence of follicle-ripening or ovulation.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Promotion of controlled superovulation

Population group: women, only adults (18 - 65 years old)

In combination with FSH or HMG, promotion of controlled superovulation in medically assisted reproduction programmes.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Chorionic gonadotrophin (human) is contraindicated in the following cases:

Thyroid disorders, adrenal disorders, pituitary disorders

at least one of
Disorder of thyroid gland
Disorder of adrenal gland
Pituitary disease

Uterine leiomyoma

Uterine leiomyoma

Abnormal vaginal bleeding

Abnormal vaginal bleeding

Breast tumours

Neoplasm of breast

Uterine tumours

Neoplasm of uterus

Ovarian tumours

Neoplasm of ovary

Malformations of the reproductive organs

Congenital malformation of genital organs

Testicular tumours, carcinoma of the prostate

at least one of
Neoplasm of testis
Carcinoma of prostate

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: PREGNYL 5000IU Powder for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈